20/09/22 -"Our target price hike is a result of upgraded estimates, which have an impact across the intrinsic as well as relative valuation metrics."
Pages
51
Language
English
Published on
20/09/22
You may also be interested by these reports :
03/11/25
Puig delivered an impressive Q3 25, beating expectations with extraordinary momentum in makeup and solid progress in Asia. The group raised its FY25 ...
30/10/25
Haleon’s Q3 sales aligned with expectations, driven by growth in Oral Health, VMS, Pain Relief, and Digestive Health. This was partially offset by ...
30/10/25
Essity delivered a profit beat for Q3 2025, with an Adj. EBITA of SEK 5,056m and an impressive 14.6% margin, exceeding consensus despite in-line net ...
29/10/25
Reckitt delivered estimate-beating Q3 2025 sales of £3.61bn, up a robust 7.0%, driven by sequential volume improvements and solid emerging markets ...